2019
DOI: 10.1016/j.atherosclerosis.2019.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
38
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(42 citation statements)
references
References 27 publications
4
38
0
Order By: Relevance
“…To validate that exosome shedding aggravated fatty liver development induced by an AMPKa1 deficiency in vivo, we inhibited exosome secretion with intraperitoneal injections of GW4869 (0.5 mg/kg/day) in HFD-fed Prkaa1 2/2 and Prkaa1 fl/fl :Adipo Cre1 mice for 8 weeks. GW4869 is a ceramide-induced exosome inhibitor (32). Consistent with its known function, GW4869 administration significantly reduced exosome secretion from WAT (Fig.…”
Section: Blocking Exosome Shedding Ablates Hfd-induced Naflsupporting
confidence: 68%
See 1 more Smart Citation
“…To validate that exosome shedding aggravated fatty liver development induced by an AMPKa1 deficiency in vivo, we inhibited exosome secretion with intraperitoneal injections of GW4869 (0.5 mg/kg/day) in HFD-fed Prkaa1 2/2 and Prkaa1 fl/fl :Adipo Cre1 mice for 8 weeks. GW4869 is a ceramide-induced exosome inhibitor (32). Consistent with its known function, GW4869 administration significantly reduced exosome secretion from WAT (Fig.…”
Section: Blocking Exosome Shedding Ablates Hfd-induced Naflsupporting
confidence: 68%
“…2F). To determine whether reduced CD63 mediated AMPKa1 deficiencyenhanced exosome secretion, adipocytes were treated with the ceramide-induced exosome inhibitor GW4869 (32). GW4869 enhanced CD63 protein levels (Supplementary Fig.…”
Section: Ampka1 Deficiency Enhances Exosome Release Independently Of Cd63mentioning
confidence: 99%
“…Based on our observation that Stx2‐Exo induce death of Gb 3 ‐expressing recipient cells (see Figure 3), we hypothesised that blockade of exosome biogenesis and secretion may reduce or prevent exosome‐mediated death of HK‐2 cells. To reduce exosome biogenesis, D‐THP‐1 cells were treated with 20 μM of the neutral sphingomyelinase (nSMase) inhibitor GW4869 prior to intoxication with Stx2; the inhibitor prevents exosome biogenesis (Wang et al, 2019). Treatment of D‐THP‐1 cells with GW4869 alone did not result in cell death, as detected by LDH release assay (data not shown).…”
Section: Resultsmentioning
confidence: 99%
“…The KEGG pathways analysis suggested that DEGs were significantly involved in focal adhesion, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, ECM-receptor interaction, amoebiasis, and chemokine signaling pathway. Previous studies showed that the dysfunction of cell adhesion, immune response, inflammatory response, focal adhesion, PI3K-Akt signaling pathway, chemokine signaling pathway, cytokine-cytokine receptor interaction, and ECM-receptor interaction can cause changes in the vascular structure of aneurysms [25][26][27][28].…”
Section: Discussionmentioning
confidence: 99%